Literature DB >> 17308009

The RISK of ROCK.

Olivier C Manintveld1, Pieter D Verdouw, Dirk J Duncker.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17308009     DOI: 10.1152/ajpheart.00179.2007

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


× No keyword cloud information.
  4 in total

1.  Rescue treatment with a Rho-kinase inhibitor normalizes right ventricular function and reverses remodeling in juvenile rats with chronic pulmonary hypertension.

Authors:  Emily Z Xu; Crystal Kantores; Julijana Ivanovska; Doreen Engelberts; Brian P Kavanagh; Patrick J McNamara; Robert P Jankov
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-01       Impact factor: 4.733

Review 2.  RhoA/Rho-kinase and vascular diseases: what is the link?

Authors:  Kenia Pedrosa Nunes; Christine S Rigsby; R Clinton Webb
Journal:  Cell Mol Life Sci       Date:  2010-07-29       Impact factor: 9.261

3.  The combination approach with Rhokinase inhibition and mechanical circulatory support in myocardial ischemia-reperfusion injury: Rho-kinase inhibition and ventricular unloading.

Authors:  Shunsuke Miyahara; Alexander Jenke; Mariam Yazdanyar; Julia Kistner; Moritz Benjamin Immohr; Yukiharu Sugimura; Hug Aubin; Hiroyuki Kamiya; Yutaka Okita; Artur Lichtenberg; Payam Akhyari
Journal:  Asian Cardiovasc Thorac Ann       Date:  2022-07-15

4.  Rho-kinase-dependent F-actin rearrangement is involved in the inhibition of PI3-kinase/Akt during ischemia-reperfusion-induced endothelial cell apoptosis.

Authors:  Melanie van der Heijden; Amanda M G Versteilen; Pieter Sipkema; Geerten P van Nieuw Amerongen; Rene J P Musters; A B Johan Groeneveld
Journal:  Apoptosis       Date:  2008-03       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.